Barclays
HIMS icon

Barclays’s Hims & Hers Health HIMS Stock Holding History

Barclays’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67M Hold
250,000
– – ﹤0.01% 1550
2026
Q1 		$5.19M Sell
250,000
-30,000
-11% -$709K ﹤0.01% 1797
2025
Q4 		$9.09M Buy
280,000
+30,000
+12% +$1.28M ﹤0.01% 1751
2025
Q3 		$14.2M Sell
250,000
-41,600
-14% -$2.13M ﹤0.01% 1422
2025
Q2 		$14.5M Buy
291,600
+250,000
+601% +$11.3M ﹤0.01% 1313
2025
Q1 		$1.23M Buy
+41,600
New +$1.55M ﹤0.01% 2976

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barclays's HIMS Position: Q2 2026 in Review

Barclays increased its Hims & Hers Health (HIMS) stake by 35% in Q2 2026, buying an estimated $5.95M and bringing the position to 861,006 shares worth $29.9M. The position accounts for 0.01% of the portfolio, ranked #933.

Barclays first reported a position in HIMS in Q1 2022 and has held it in 18 quarters since. The position peaked at $37.4M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Barclays held 861,006 shares of Hims & Hers Health worth $29.9M as of Q2 2026.
  • Barclays bought 221,634 Hims & Hers Health shares in Q2 2026, an estimated $5.95M.
  • Hims & Hers Health made up 0.01% of Barclays's portfolio in Q2 2026, its #933 holding.
  • Barclays first reported a position in Hims & Hers Health in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Hims & Hers Health position peaked at $37.4M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.